GlaxoSmithKline Takes Biggest Slice of Swine Flu Market Published: Oct 30, 2009 Reuters -- GlaxoSmithKline (GSK.L) is on track to reap the biggest H1N1 swine flu windfall among major drugmakers, according to latest information from companies. Related links Reuters This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news